Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis

Leigh Ellis, Kristin Lehet, Sheng Yu Ku, Gissou Azabdaftari, Roberto Pili

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Progression to metastatic disease is the primary cause of mortality in men with prostate cancer (PCa). Mouse models which progress with spontaneous metastasis are limited. Such models would allow for extensive studies of molecular mechanisms of metastasis, and more definite pre- clinical therapy trials. Orthotopic murine models have been described; however a limiting biology of these models is their lack of an intact immune system. Within, we describe the development of an androgen sensitive and castrate resistant tractable orthotopic murine syngeneic (immune competent) model of prostate cancer. Both models develop primary tumors which spontaneously progress to metastatic disease in lymph tissue. These models will allow for more complete mechanistic and therapeutic studies in a short time period.

Original languageEnglish (US)
Pages (from-to)609-613
Number of pages5
JournalOncoscience
Volume1
Issue number10
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Neoplasm Metastasis
Transplants
Lymph
Androgens
Immune System
Clinical Trials
Mortality
Therapeutics
Neoplasms

Keywords

  • Castrate resistant prostate cancer
  • Metastasis
  • Mouse models
  • MYC
  • Prostate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis. / Ellis, Leigh; Lehet, Kristin; Ku, Sheng Yu; Azabdaftari, Gissou; Pili, Roberto.

In: Oncoscience, Vol. 1, No. 10, 2014, p. 609-613.

Research output: Contribution to journalArticle

Ellis, Leigh ; Lehet, Kristin ; Ku, Sheng Yu ; Azabdaftari, Gissou ; Pili, Roberto. / Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis. In: Oncoscience. 2014 ; Vol. 1, No. 10. pp. 609-613.
@article{0d56865806934a4999dbed14f7858560,
title = "Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis",
abstract = "Progression to metastatic disease is the primary cause of mortality in men with prostate cancer (PCa). Mouse models which progress with spontaneous metastasis are limited. Such models would allow for extensive studies of molecular mechanisms of metastasis, and more definite pre- clinical therapy trials. Orthotopic murine models have been described; however a limiting biology of these models is their lack of an intact immune system. Within, we describe the development of an androgen sensitive and castrate resistant tractable orthotopic murine syngeneic (immune competent) model of prostate cancer. Both models develop primary tumors which spontaneously progress to metastatic disease in lymph tissue. These models will allow for more complete mechanistic and therapeutic studies in a short time period.",
keywords = "Castrate resistant prostate cancer, Metastasis, Mouse models, MYC, Prostate cancer",
author = "Leigh Ellis and Kristin Lehet and Ku, {Sheng Yu} and Gissou Azabdaftari and Roberto Pili",
year = "2014",
doi = "10.18632/oncoscience.88",
language = "English (US)",
volume = "1",
pages = "609--613",
journal = "Oncoscience",
issn = "2331-4737",
publisher = "Impact Journals",
number = "10",

}

TY - JOUR

T1 - Generation of a syngeneic orthotopic transplant model of prostate cancer metastasis

AU - Ellis, Leigh

AU - Lehet, Kristin

AU - Ku, Sheng Yu

AU - Azabdaftari, Gissou

AU - Pili, Roberto

PY - 2014

Y1 - 2014

N2 - Progression to metastatic disease is the primary cause of mortality in men with prostate cancer (PCa). Mouse models which progress with spontaneous metastasis are limited. Such models would allow for extensive studies of molecular mechanisms of metastasis, and more definite pre- clinical therapy trials. Orthotopic murine models have been described; however a limiting biology of these models is their lack of an intact immune system. Within, we describe the development of an androgen sensitive and castrate resistant tractable orthotopic murine syngeneic (immune competent) model of prostate cancer. Both models develop primary tumors which spontaneously progress to metastatic disease in lymph tissue. These models will allow for more complete mechanistic and therapeutic studies in a short time period.

AB - Progression to metastatic disease is the primary cause of mortality in men with prostate cancer (PCa). Mouse models which progress with spontaneous metastasis are limited. Such models would allow for extensive studies of molecular mechanisms of metastasis, and more definite pre- clinical therapy trials. Orthotopic murine models have been described; however a limiting biology of these models is their lack of an intact immune system. Within, we describe the development of an androgen sensitive and castrate resistant tractable orthotopic murine syngeneic (immune competent) model of prostate cancer. Both models develop primary tumors which spontaneously progress to metastatic disease in lymph tissue. These models will allow for more complete mechanistic and therapeutic studies in a short time period.

KW - Castrate resistant prostate cancer

KW - Metastasis

KW - Mouse models

KW - MYC

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84923277322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923277322&partnerID=8YFLogxK

U2 - 10.18632/oncoscience.88

DO - 10.18632/oncoscience.88

M3 - Article

AN - SCOPUS:84923277322

VL - 1

SP - 609

EP - 613

JO - Oncoscience

JF - Oncoscience

SN - 2331-4737

IS - 10

ER -